These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25870772)

  • 1. Models for the directed evolution of bacterial allelopathy: bacteriophage lysins.
    Bull JJ; Crandall C; Rodriguez A; Krone SM
    PeerJ; 2015; 3():e879. PubMed ID: 25870772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel
    Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
    mSphere; 2017; 2(2):. PubMed ID: 28357414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes.
    Kwon SJ; Kim D; Lee I; Kim J; Dordick JS
    Biotechnol Bioeng; 2017 Aug; 114(8):1648-1657. PubMed ID: 28369698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.
    Dreher-Lesnick SM; Schreier JE; Stibitz S
    Viruses; 2015 Dec; 7(12):6675-88. PubMed ID: 26694451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study.
    Allen RC; Brown SP
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage lysins as effective antibacterials.
    Fischetti VA
    Curr Opin Microbiol; 2008 Oct; 11(5):393-400. PubMed ID: 18824123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens.
    Fischetti VA
    Curr Top Microbiol Immunol; 2017; 409():529-540. PubMed ID: 26728063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci.
    Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC
    Front Microbiol; 2020; 11():574739. PubMed ID: 33324362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy Between Two Chimeric Lysins to Kill
    Vázquez R; García P
    Front Microbiol; 2019; 10():1251. PubMed ID: 31231338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal virolysin, a phage-induced lysin; its differentiation from the autolysis of normal cells.
    RALSTON DJ; LIEBERMAN M; BAER B; KRUEGER AP
    J Gen Physiol; 1957 May; 40(5):791-807. PubMed ID: 13428989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered bacteriophage lysins as novel anti-infectives.
    Yang H; Yu J; Wei H
    Front Microbiol; 2014; 5():542. PubMed ID: 25360133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins.
    Gerstmans H; Grimon D; Gutiérrez D; Lood C; Rodríguez A; van Noort V; Lammertyn J; Lavigne R; Briers Y
    Sci Adv; 2020 Jun; 6(23):eaaz1136. PubMed ID: 32537492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysin LysMK34 of
    Abdelkader K; Gutiérrez D; Grimon D; Ruas-Madiedo P; Lood C; Lavigne R; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32709718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lysins of bacteriophages infecting lactic acid bacteria.
    Sable S; Lortal S
    Appl Microbiol Biotechnol; 1995 Apr; 43(1):1-6. PubMed ID: 7766123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.
    São-José C
    Antibiotics (Basel); 2018 Mar; 7(2):. PubMed ID: 29565804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel "Superspreader" Bacteriophages Promote Horizontal Gene Transfer by Transformation.
    Keen EC; Bliskovsky VV; Malagon F; Baker JD; Prince JS; Klaus JS; Adhya SL
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphism Drives Susceptibility Between Bacteria and Bacteriophages.
    Zhang X; Xiong D; Yu J; Yang H; He P; Wei H
    Front Microbiol; 2021; 12():627897. PubMed ID: 33841354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.